Geneva, Oct. 21 -- International Clinical Trials Registry received information related to the study (NCT07204652) titled 'Colonoscopic Detection of Phosphorylated Alpha-synuclein for Parkinson's Diagnosis' on Sept. 24.
Study Type: Observational
Primary Sponsor: CND Life Sciences
Condition:
PARKINSON DISEASE (Disorder)
Parkinson
Parkinson's Disease and Parkinsonism
Parkinson Disease
Intervention:
Diagnostic Test: No Intervention: Observational Cohort
Recruitment Status: Recruiting
Date of First Enrollment: September 3, 2025
Target Sample Size: 20
Countries of Recruitment:
United States
To know more, visit https://clinicaltrials.gov/study/NCT07204652
Published by HT Digital Content Services with permission from Health Daily D...